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Department of Biological Sciences
Abstract
Our multidisciplinary group at the University of Arkansas 
has been investigating the suitability of the chicken as a medical 
model for pulmonary arterial hypertension (PAH) in humans. 
There are several forms of PAH in humans arising from elevated 
pulmonary arterial pressure and pulmonary vascular resistance. 
Spontaneous cases of PAH are known as idiopathic PAH (IPAH), 
where the exact physiological causes are not known. IPAH patients 
that do not respond to standard treatments have a prognosis of 
only a few years. Currently, there is no acceptable animal model 
for IPAH. As part of our effort to pursue the chicken as model 
for IPAH, we have mapped chromosomal regions associated with 
susceptibility to ascites, an industry term for PAH in chickens. 
One region identified contains the angiotensin II type 1 receptor 
gene (AGTR1), a gene known to be associated with particular 
forms of PAH in humans. My project was to sequence the exonic 
regions of AGTR1 from chickens selected for susceptibility and 
resistance to ascites. I identified a total of 15 single nucleotide 
polymorphisms (SNPs) in intronic regions and 9 affecting exonic 
sequences that distinguish resistant and susceptible birds. One of 
the SNPs alters the encoded protein, but more sequencing data 
is needed to confirm the presence of this SNP. The 24 SNPs have 
become the basis for further genotypic efforts using quantitative 
polymerase chain reaction high-resolution melt (qPCR-HRM) 
assays to determine the association of alternative alleles of 
AGTR1 with PAH in the chicken. This knowledge will help the 
poultry industry in genetic selection to reduce incidence of ascites. 
Characterization of the genetic determinants of ascites in the 
chicken will also identify specific gene networks and further our 
understanding of PAH in humans. 
Introduction
Pulmonary arterial hypertension (PAH) is currently accepted 
as being classified into three main types: 1) idiopathic pulmonary 
arterial hypertension (IPAH), 2) familial pulmonary arterial 
hypertension (FPAH), and 3) pulmonary arterial hypertension 
related to associated conditions or risk factors (APAH) 
(simmonneau et al., 2004). IPAH and FPAH have also been 
classified as types of primary pulmonary hypertension, meaning 
they have no known cause. APAH has been classified as secondary 
pulmonary hypertension because the hypertension is believed to be 
due to an underlying cause.
IPAH results in increases in pulmonary arterial pressure 
and in pulmonary vascular resistance, which ultimately causes 
right ventricular failure and death if untreated or unresponsive 
to treatment (Widlitz and Barst, 2003). the increased vascular 
resistance in patients with pulmonary hypertension is due to 
vasoconstriction, thrombosis in situ, and vascular remodeling 
(Rubin, 1997). Primary pulmonary hypertension, including IPAH, 
is defined as having a mean pulmonary artery pressure of 25 
mmHg or greater at rest or 30 mmHg or greater during exercise, 
with no related underlying condition (Widlitz and Barst, 2003). 
IPAH is diagnosed in one to two new patients per million each 
year, with an average survival of 2.5 years after initial diagnosis 
(Rubin, 1997).
Adults with primary pulmonary hypertension generally 
develop plexiform lesions and seemingly irreversible pulmonary 
vascular changes (Widlitz & Barst, 2003). these vascular changes 
are phenotypic changes in the endothelial and smooth muscle cells 
in pulmonary arteries and are influenced by cell proliferation, 
apoptosis, matrix proteins, and matrix turnover. Upregulation of 
the transcription factor oct-4 has been shown to be involved in 
the irregular vasculature of the pulmonary arterial smooth muscle 
cells in IPAH (Firth et al., 2010). Hemodynamic influences 
are also important in the etiology of PAH. Additionally, gene 
expression in pulmonary vascular cells is related to environmental 
factors, receptors, growth factors, signaling pathways, and genetic 
influences, all of which can interact with each other in the disease 
process.  
serotonin metabolism has been shown to be central 
to the etiology of PAH (MacLean, 2007). serotonin 
(5-hydroxytryptamine, 5Ht) can be synthesized in the pulmonary 
endothelium and released to either interact with serotonin cell 
surface receptors or enter the smooth muscle cells via the serotonin 
transporter (seRt). serotonin can act to induce proliferation 
and contraction of pulmonary smooth muscle cells through 5Ht 
receptors on the vascular epithelium. the actions of 5Ht receptors 
have been shown to be involved in PAH in humans (Humbert et 
al., 2004).  
the Renin-Angiotensin Aldosterone system (RAAs) is 
a hormonal cascade that is important in the pathogenesis of 
cardiovascular disorders (Atlas, 2007). the RAAs functions in 
maintaining the homeostasis of arterial pressure, tissue perfusion, 
and extracellular volume. the cascade begins with the secretion 
of renin by the juxtaglomerular cells of the kidneys. In the 
extracellular space, renin functions to cleave ten amino acids 
from the n-terminus of angiotensinogen, which is constitutively 
BIOLOGICAL SCIENCES: John Russell Burks
1
Burks: Sequence Analysis of the Angiotensin II Type 1 Receptor (AGTR1) G
Published by ScholarWorks@UARK, 2011
50  inquiry  Volume 12 2011
secreted by the liver. the cleaved angiotensinogen is an inactive 
ten amino acid peptide known as angiotensin I. two amino 
acids from the c-terminus of angiotensin I are cleaved by 
membrane-bound angiotensin-converting enzyme (Ace), creating 
the octapeptide, angiotensin II. Angiotensin II is the primary 
biologically active product of the RAAs and acts as a potent 
vasoconstrictor. 
At least four types of angiotensin receptors have been 
identified, but the type 1 receptor (angiotensin II type 1 receptor, 
or AGtR1) is involved in most of the known physiology 
of angiotensin II (Atlas, 2007). cardiovascular effects of 
angiotensin II and AGtR1 include vasoconstriction, increased 
blood pressure, increased cardiac contractility, and vascular and 
cardiac hypertrophy. Angiotensin II and AGtR1 have also been 
shown to stimulate aldosterone synthesis by the adrenal cortex, 
inhibit renin release, increase sodium reabsorption in the kidneys, 
and affect the sympathetic nervous system. Angiotensin II and 
AGtR1 also mediate effects on cell growth and proliferation, 
inflammatory responses, and oxidative stress. AGtR1 contains 
the seven transmembrane domains characteristic of the G protein-
coupled receptor superfamily and is found on many cell types in 
angiotensin II target organs.
the RAAs has been shown to be genetically involved in 
human PAH (chung et al., 2009). A specific polymorphism in the 
angiotensin-converting enzyme (Ace) gene has been shown to be 
associated with primary pulmonary hypertension (IPAH) and right 
ventricular function (Abraham et al., 2003). Increased expression 
of Ace has also been seen in the plexiform lesions of PAH (orte 
et al., 2000). Recent research has shown that certain variants of 
AGtR1 are significantly related to PAH. specifically, an adenine 
(A)/cytosine (c) substitution at position 1166 in the 3’ untranslated 
region of AGtR1 is significantly associated with early onset IPAH 
in humans (chung et al., 2009). this snP occurs within a potential 
target site for the miRnA-155, a microRnA (miRnA) binding site 
(ceolotto et al., 2011). they theorized that miRnA-155 can target 
the 1166A allele, but not the 1166c allele. A study of hypertensive 
subjects found that AGtR1 protein expression was negatively 
correlated with miRnA-155 expression and that AGtR1 protein 
expression was significantly greater in subjects homozygous 
for the c allele than in heterozygous (cA) or homozygous A 
subjects. this would be consistent with miRnA-155 repression 
of the 1166A alleles and lack of repression of the 1166c snP. 
overexpression of AGtR1 protein would then lead to higher blood 
pressure.
Ascites, the industry term for PAH in chickens, results from 
a fast growth rate and causes significant mortality in chickens 
(Pavlidis et al., 2007). Ascites is among the most common and 
most deadly cardiovascular conditions in modern lines of broiler 
chickens (olkowski, 2007). Increased genetic selection for fast 
growth rate and the creation of diets that stimulate fast growth 
contribute to the development of ascites in the broiler chicken 
(Julian, 1993). Pulmonary hypertension in poultry causes right 
ventricular hypertrophy, valvular insufficiency, increased venous 
pressure, and ascites. Because the chicken heart has a thin-
walled right ventricle and a muscular right atrioventricular valve, 
pulmonary hypertension causes heart failure and death quickly in 
the chicken. Also, the broiler chicken is relatively small, but has 
very large breasts, causing increased pressure on the air sacs of the 
relatively small lungs. 
the etiology of ascites in the broiler chicken begins with the 
high basal metabolic rate required for fast growth (Government 
of Alberta, 2008). Broilers are susceptible to ascites when their 
pulmonary vascular capacity cannot tolerate the cardiac output 
necessary for meeting the metabolic requirements of rapid growth, 
which could be due to anatomical or functional restrictions 
(Wideman et al., 2007). this inadequate capacity causes a deficit 
in oxygen, which in turn causes the right ventricle to increase 
the amount of blood pumped to the lungs to be oxygenated 
(Government of Alberta, 2008). Because the right ventricle is thin 
in the chicken, it often expands due to the increase in blood flow. 
the increased blood flow causes increased pulmonary arterial 
pressure and right ventricular hypertrophy. More red blood cells 
are produced by the chicken to increase the oxygen carrying 
capacity of the blood, but more red blood cells also cause the 
blood to thicken and further increase vascular resistance. Valvular 
insufficiency causes right ventricular failure and the associated 
backflow causes liver edema, which leads to leakage of plasma 
into the body cavity. this leads to an accumulation of fluid in 
the abdomen (ascites). In the poultry industry the term is also 
“water belly” and leads to either mortality or condemnation at the 
plant. Ascites can be treated in the chicken with beta agonists and 
dietary arginine, both of which increase ventilation and pulmonary 
blood flow (currie, 1999). Also, feed restriction is used to cause 
a tachycardia that may protect birds from the brachycardia 
associated with hypoxia-induced ascites.
there are several currently used animal models for human 
pulmonary hypertension, with the most common being derived 
from exposing the animal to chronic hypoxia or to monocrotaline 
injury (stenmark et al., 2009). Animals used include rats, mice, 
piglets, calves, and macaques. Fawn-hooded rats are commonly 
used because pulmonary hypertension manifests most severely in 
these animals. However, none of these develops the plexogenic 
arteriopathies found in humans and chickens. our collaborative 
group at the University of Arkansas is examining whether ascites 
in the chicken (Gallus gallus) is a medical model for PAH/IPAH. 
Ascites is easily induced in the chicken and lines of PAH resistant 
and susceptible chickens have been developed. there are genetic 
and pathophysiological similarities between ascites in the chicken 
and PAH in the human. chickens with ascites form plexogenic 
arteriopathies that are indistinguishable from plexiform lesions 
found in the lungs of humans with advanced PAH (Wideman et 
al., 2011). Genetic evidence for the chicken being an appropriate 
medical model for PAH can be found in our group’s identification 
of chromosomal regions associated with ascites in the chicken 
that contain genes that have been found to be involved in PAH in 
humans (chung et al., 2009; MacLean, 2007; orte et al., 2000; 
smith, 2009). 
A number of methods have been employed to induce PAH in 
the chicken, including injection of bacterial lipopolysaccharide 
(LPs), injection of micro-particles of cellulose, and exposure to 
hypoxia to simulate high altitudes, such as growth in a hypobaric 
chamber (chapman et al., 2005; currie, 1999; Pavlidis, 2007). 
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Dr. nicholas Anthony (University of Arkansas) has developed 
divergently selected lines of broiler chickens that are resistant 
(Res) or susceptible (sUs) to ascites using a hypobaric chamber 
to induce the disease (Pavlidis, 2007). the chamber simulated 
high altitude conditions via a partial vacuum to lower the partial 
pressure of oxygen in the chamber. the Res and sUs lines were 
created based on sib-selection over successive generations in the 
hypobaric chamber. 
our group then used a cross of the Res and sUs lines to 
map several chromosomal segments contributing to PAH in the 
chicken (smith, 2009). one of those regions contains a serotonin 
receptor-transporter (5Ht receptor), which has been associated 
with some forms of human PAH (MacLean, 2007). Another region 
contained the Ace gene. those genes are under investigation 
by other students in the laboratory. A third region contains the 
gene AGtR1, which is located on chromosome 9 and codes for 
the angiotensin II type 1 receptor. As already mentioned, this 
gene and the RAAs have been shown to be involved in PAH in 
humans (Atlas, 2007; chung et al., 2009). the implications of our 
preliminary data is that mis-regulation of angiotensin II production 
by Ace and the subsequent response by AGtR1 may be a 
contributing factor for development of ascites.  
Understanding the genetics of PAH in the chicken model will 
identify specific gene networks and will advance understanding 
of the underlying processes leading to PAH in humans. this 
knowledge may also lead to genetic selection in the poultry 
industry to lessen the economic losses associated with ascites.
the region containing the AGtR1 gene on chromosome 
9 (Gga9) was previously associated with ascites in the chicken 
through a whole genome association study and then confirmed 
using variable number tandem repeat (VntR) genotyping (smith, 
2009). Further research in our laboratory has associated this region 
with ascites in our lines and in three commercial lines (sriram 
Krishnamoorthy, personal communication). therefore, this region 
appears to contain a major determinant of ascites susceptibility in 
chickens. A region in the human genome that contains the AGtR1 
gene has been associated with some forms of PAH, thus it is likely 
that mutations affecting the AGtR1 gene could contribute to 
ascites in chickens. 
 My research project was to sequence the AGtR1 gene from 
the resistant and susceptible lines to determine whether mutations 
could be found that represent alternative alleles of AGtR1. I then 
developed qPcR-HRM assays for the alternative alleles of AGtR1 
for use in genotyping a larger collection of DnAs. Additional 
genotype data will determine whether these particular mutations 
are associated with susceptibility to PAH. As depicted in Figure 
1, the chicken AGtR1 gene’s three exons are distributed across 
20,979 bases (Gga 9: 13,475,625 – 13,496,603), with the entire 
coding sequence located in exon 3 (International chicken Genome 
sequencing consortium, 2004). the three exons produce a final 
mRnA transcript of 1427 bases. the first two exons are non-
coding while the final exon encodes a predicted 359 amino acid 
protein that is the receptor. 
Materials and Methods
DNA Isolation
DnAs were previously isolated by sriram Krishnamooorthy, 
Ph.D. candidate University of Arkansas, from chickens that were 
then phenotyped in a hypobaric chamber. these DnAs have 
been previously validated by others in our laboratory for PcR 
amplification of numerous regions. 
Primer Design for Polymerase Chain Reaction (PCR)
the genomic region representing AGtR1 was downloaded 
from the Ucsc genome browser. Primer3 (http://frodo.wi.mit.edu/
primer3/) was used to design oligonucleotide primers covering 
all of the exonic regions. Primers were synthesized by eurofins-
operon. PcR conditions were then optimized for primer pairs. 
Polymerase Chain Reaction (PCR)
PcR mixtures were assembled incorporating H
2
o, PcR 
Buffer, deoxyribonucleotide triphosphate (dntPs), taq 
polymerase, primers, and target DnA. twenty µl PcR mixtures 
contained 1X PcR Buffer (50 mM triscl, 1 mM Mgcl
2
, 3 mg/
ml BsA), 0.2 mM dntPs, 3 units taq polymerase, 2 µl target 
DnA, and 1 µM forward and reverse primer mixture. Reactions 
for sequencing consisted of 200 µl of the same concentrations of 
1X PcR Buffer, 0.2 mM dntPs, 1 µM forward and reverse primer 
mixture, but differed by using 10 units taq polymerase, and 5 µl 
target DnA. Reactions were cycled in one of four PcR machines 
in our laboratory to obtain amplicons of the three exons of AGtR1 
in the resistant and susceptible birds. 
Gel Electrophoresis for Quality of PCR Product
A portion of the PcR product was resolved on a 1.5% agarose 
gel to evaluate the quality of the product. Five µl of PcR product 
was mixed with 5 µl of loading dye prior to loading into gel. the 
loading dye used was 10 µg/ml ethidium bromide (ethBr), 15% 
Ficoll, 20mM eDtA, 0.1% Bromophenol Blue 0.1% Xylene 
cyanol. Molecular weight ladder was pGeM5 digested with 
sau3A. Gels were submerged in 0.5X tBe with 0.5 µg/ml ethBr 
and electrophoresed for approximately 5-10 minutes at 40 Volts 
Figure 1:  Ucsc genome browser view of the chicken AGtR1 gene on chromosome 9 (International chicken Genome sequencing consortium, 2004).   
http://genome.ucsc.edu.
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(V) and then for approximately 90 minutes at 70 V. 
Gel Imaging
Gels were imaged either using an Ultraviolet transilluminator 
captured with a ccD camera and FlashPoint FPG software, or the 
gels were scanned at 600nm using a Model 9600 typhoon Imager 
(Ge Healthcare) and analyzed with ImageQuant software.
Purification and Quantification of PCR product
to purify DnA samples for sequencing, reactions were diluted 
1x with te (10 mM triscl, 1 mM eDtA, pH 7.5) and extracted 
with phenol:chloroform:isoamyl alcohol (50:48:2) and then with 
chloroform:isoamyl alcohol (24:1). the solution was brought to 
0.3 M with sodium acetate and DnA precipitated by addition of 3 
volumes of 95% ethanol. the mixture was incubated at -20°c for 
1-2 hours and then DnAs were collected by centrifugation (10 min 
at 10,000 rpm). the pellet was rinsed with cold 70% ethanol, dried 
under vacuum and redissolved in 10 mM triscl, 0.1 mM eDtA. 
DnA was quantified using a Model tKo 100 Hoefer scientific 
Instruments DnA Fluorometer according to the manufacturer’s 
instructions. 
DNA Sequencing and Analysis 
Purified PcR products (5-20 ng) were mixed with 3.4 pM 
of individual primers, and submitted to the UA DnA Resource 
center for capillary sequencing. the sequence files were aligned 
using seqman software from DnAstar. 
Quantitative PCR – High Resolution Melt (qPCR-HRM) 
Assays for SNPlotyping
Primers were designed that flank single nucleotide 
polymorphisms (snPs) to generate a short amplicon (generally 
less than 60 base pairs). the oligonucleotide primers were 
designed using Primer3 (http://frodo.wi.mit.edu/primer3/) and 
were synthesized by eurofins-operon. 
twenty µl PcR reactions each contained 1X PcR Buffer 
(50 mM triscl, 1 mM Mgcl
2
, 3 mg/ml BsA), 0.2 mM dntPs, 3 
units taq polymerase, 1 µl target DnA, 1 µM forward and reverse 
primer mixture, H
2
o, and an intercalating dye (sYBR Green, 
LcGreen, or evaGreen). the qPcR-HRM assay was performed 
on a BioRad cFX96 Real-time system. the protocol used 
included the following steps: 1) 95°c for 30 seconds, 2) 95°c for 
15 seconds, 3) 50°c for 15 seconds, 4) 72°c for 30 seconds and 
plate read, 5) Repeat steps 2-4 39 times, 6) 72°c for 3 minutes, 7) 
95°c for 3 minutes, 8) 65°c for 3 minutes, and 9) Gradient from 
65°c-90°c at 0.1°c increments for 10 seconds with plate read at 
each increment.
Results
I designed four pairs of oligonucleotide primers that amplify 
the three exonic regions of the AGtR1 gene. the size of exon 
3 required the use of two pairs of primers, while exons 1 and 
2 required one pair each. two additional pairs of primers were 
designed to flank exon 3 because the original pair flanking one 
portion of exon 3 produced no PcR product. All primers were 
optimized for annealing temperatures and cycling conditions using 
chicken genomic DnA. the primer pair names, sequences, and 
optimized PcR conditions are shown in tables 1 and 2.
the primer pair for exon 1 (AGtR1 X1 F1/R1) was optimized 
for 20 µl PcRs but no product was obtained when a 200 µl PcR 
was performed for sequencing. the AGtR1 X3-2 F1/R1 primer 
pair did not produce a PcR product.  
Quality amplicons of exons 2 and 3 were obtained from 
200 µl PcR reactions, purified, and sequenced. sequences 
were obtained from two of the three AGtR1 exonic regions 
from several resistant and susceptible birds (usually 3 of each). 
the sequences were aligned with the AGtR1 gene from the 
2006 genome assembly of the Red Jungle Fowl (Gallus gallus) 
sequence. the alignments for exon 2 and exon 3 are presented in 
Figures 2 and 3, respectively. 
comparisons between Jungle Fowl, resistant, and susceptible 
sequences identified 24 single nucleotide polymorphisms (snPs), 
four of which affected the AGtR1 coding sequence. All identified 
snPs are listed in table 3. Fourteen snPs were found in the 
intronic sequence 5’ of exon 2 and three snPs were found within 
exon 2. one snP was found in the intronic sequence 5’ of exon 
3. six snPs were identified in exon 3 including one snP in the 3’ 
untranslated region (UtR). 
Five pairs of primers were designed to amplify specific snPs 
in exons 2 and 3 for high resolution melt analyses. two primers 
designed to amplify regions containing snPs were optimized 
using genomic chicken DnA and are ready to be used in a 
snPlotyping application. three of the five primer pairs designed 
to amplify the snP regions were not optimized.
A LcGreen qPcR-HRM assay to snPlotype multiple resistant 
and susceptible chickens was completed for the snP located at 
base 2513. the AGtR1_2513F/R primer pair was used and the 
melt curve is shown in Figure 4. 
Discussion
several polymorphisms were identified that establish that 
there are at least two forms of the AGtR1 gene in our Res and 
sUs lines (Pavlidis, 2007). the 14 snPs found in the intronic 
region 5’ of exon 2 and the three snPs in exon 2 do not affect 
the coding region for the AGtR1 protein, as these snPs are in 
non-coding regions. two snPs, one in the intronic region 5’ of 
exon 3 and one in exon 3, need more sequence from additional 
chickens for confirmation. sequence data was only obtained from 
two individuals, both resistant, for each of these two snPs. the 
intronic snP would have no effect on the protein sequence, but 
the snP in exon 3 is in the first position of a proline codon at 
position 82 of the protein (Pro82) and would change the encoded 
amino acid to serine. Proline residues are normally considered as 
disrupters of secondary structure. this proline is located within the 
extracellular portion of the alpha helical transmembrane II domain 
(G Protein-coupled Receptor Database, 2011). Because of its 
location outside of the hydrophobic membrane, replacement of the 
proline with a hydrophilic serine would not alter the hydrophilicity 
of the region but certainly could alter a secondary structure. Pro82 
is highly conserved in human, cow, mouse, rat, opossum, lizard, 
frog, and zebrafish (see Figure 5). Four other snPs found in exon 
3 are located in the third codon position (i.e., the wobble position) 
and would be silent with respect to the encoded protein. the 
specific codon changes are shown in table 3. 
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the snP found in the 3’ UtR of exon 3 was not found to be 
analogous to the 3’ UtR snP found to be associated with PAH by 
chung et al (2009). the snP in the human AGtR1 gene was 86 
bases 3’ to the terminator codon, but the snP found in the chicken 
was 13 bases 3’ to the stop codon. However, this snP may still be 
of importance in terms of its potential effects on miRnA binding 
sites. there are several miRnA binding sites located in the 3’ 
UtRs of the human AGtR1 mRnA, so snPs located in one of 
these binding sites could have an effect on miRnA function and 
gene expression (elton et al., 2010). Perhaps the snP found in 
the 3’ UtR of the chicken is localized in a miRnA binding site or 
creates a novel miRnA binding site, both of which could affect 
miRnA function and gene expression. 
new primers may need to be designed to amplify exon 
3 and three of the snP regions, while a different strategy or 
primer redesign may be necessary to obtain sequence for exon 
1. sequence data needs to be obtained for exon 1 and additional 
sequence data is needed for the first portion of exon 3. Also, more 
work can be done to determine whether any particular AGtR1 
allele is associated with PAH susceptibility. one approach used 
in our laboratory is the development of qPcR-HRM (quantitative 
PcR High-Resolution Melt) assays for snPlotyping a collection 
of DnAs representing different susceptible and resistant lines. 
two of the five snP primers I designed are ready for this analysis, 
whereas three others need further optimization or need to be 
redesigned. statistical analysis of the frequency of each snPlotype 
can be performed to determine whether there is an association of 
any of these snPs with ascites phenotype. In addition, based on 
frequencies and concordance, it can be determined which snPs 
are in linkage and define different particular haplotypes (alleles) 
for AGtR1.
the melt curve obtained from a qPcR-HRM assay for 
the snP located at base 2513 showed insufficient allelic 
discrimination (data not shown). that is, the melting temperatures 
were not significantly different between the resistant and 
susceptible chickens so as to determine that there are or are not 
two alleles. Additional analysis using qPcR-HRM assays are 
being pursued to examine additional snPs identified in AGtR1. 
A Ph.D. candidate in the lab is currently using qPcR 
on cDnA to study expression levels of AGtR1 in different 
tissues from resistant and susceptible chickens. He has detected 
significant differences in expression of AGtR1 in RnA from 
whole blood. With qPcR-HRM assays we should be able to 
correlate expression levels with particular alleles to determine 
whether the allelic effect is associated with differences in 
expression or the protein product. 
Further genetic analysis of the different forms of the AGtR1 
gene from both susceptible and resistant birds will lead to insight 
into how particular mutations in the gene may contribute to the 
development of ascites in the chicken. It is this knowledge of the 
genetics of ascites in chickens that will lead to genetic selection 
to reduce ascites in chickens, and further develop the chicken as 
a medical model for PAH in humans. Availability of an animal 
medical model will provide the means to develop and evaluate 
new treatments for PAH in humans.
 
Table 3:  SNP Information.  Jungle Fowl genotype was obtained from the 2006 assembly of Red Jungle Fowl (Gallus gallus) 
(International Chicken Genome Sequencing Consortium, 2004).  Codon Change is relative to the Jungle Fowl sequence.  *More 
sequence data is needed to confirm.  
 
  
SNP Region Locus (bp) Jungle Fowl 
Genotype
Resistant 
Genotype(s)
Susceptible    
Genotype(s)
Codon Change
Intronic region 5' of exon 2 1996 CC CC TT N/A
Intronic region 5' of exon 2 2011 TT TT CC, C/T N/A
Intronic region 5' of exon 2 2114 GG AA GG, G/A N/A
Intronic region 5' of exon 2 2180 GG AA GG, G/A N/A
Intronic region 5' of exon 2 2190 CC TT CC, C/T N/A
Intronic region 5' of exon 2 2228 No Base AA AA N/A
Intronic region 5' of exon 2 2235 AA AA TT, A/T N/A
Intronic region 5' of exon 2 2413 GG GG AA, A/G N/A
Intronic region 5' of exon 2 2418 GG GG TT, G/T N/A
Intronic region 5' of exon 2 2422 CC CC TT, C/T N/A
Intronic region 5' of exon 2 2423 AA AA GG, G/A N/A
Intronic region 5' of exon 2 2425 TT TT AA, A/T N/A
Intronic region 5' of exon 2 2448 TT TT GG, G/T N/A
Intronic region 5' of exon 2 2503 CC CC TT, C/T N/A
First base of exon 2 2513 GG AA GG, G/A N/A
Exon 2 2608 No Base TT No Base N/A
Exon 2 2687 No Base No Base GG N/A
*Intronic region 5' of exon 3 20991 AA TT No Data N/A
*Exon 3 21361 CC C/T No Data CCA (Pro) to TCA (Ser)
Exon 3 21618 TT TT CC, C/T CGT (Arg) to CGC (Arg)  
Exon 3 21945 CC CC TT, C/T ATC (Ile) to ATT (Ile)
Exon 3 21987 CC TT CC, C/T ATT (Ile) to ATC (Ile)
Exon 3 22050 AA GG AA, A/G AAA (Lys) to AAG (Lys)
UTR 3' of exon 3 22210 TT CC TT, C/T N/A
Table 3:  snP Information.  Jungle Fowl genotype was obtained from the 2006 assembly of Red Jungle Fowl (Gallus gallus) (International chicken Genome 
sequencing consortium, 2004).  codo  change is relative to the Jungle Fowl sequence.  *More sequence data is needed to confirm. 
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Mentor Comments: Dr. Rhoads’ comments place Russell’s work 
into the larger context of a major interdisciplinary research initia-
tive that showcases some of the most exciting work taking place 
on the University of Arkansas campus.
Russell Burks’ sequence analyses of the AGTR1 gene is part 
of a collaborative project between several research groups on 
the University of Arkansas campus investigating Pulmonary 
Arteriole Hypertension (PAH) in the chicken. PAH results in a 
disease known as Ascites in the poultry industry with annual 
costs estimated at over $100,000,000. During the past 15 
years, Dr. Nicholas Anthony in Poultry Science developed 
ascites susceptible and ascites resistant lines of chickens. We 
then collaborated on mapping the gene regions contributing 
to ascites phenotype. One gene region contained the AGTR1 
gene which, in humans, has been implicated in some forms of 
PAH. Sriram Krishnamoorthy (Ph.D. student in Dr. Anthony’s 
group) has confirmed that the region of AGTR1 is associated 
with Ascites phenotype in the experimental lines and in 
commercial lines. 
Therefore, Russell took on the task of sequencing the AGTR1 
gene from the resistant and susceptible lines. He used PCR to 
amplify the exonic regions from multiple chickens. Sequences 
of those regions revealed a number of single nucleotide 
polymorphisms (SNPs). Some of these SNPs are not in exons, 
while a few affect exonic sequences including one that would 
alter the AGTR1 protein. Although none of these SNPs may be 
the actual mutation that contributes to ascites susceptibility/
resistance, they are excellent markers for investigating this 
region further. AGTR1 is part of the angiontensin pathway 
which regulates vasoconstriction and kidney function. Dr. 
Robert Wideman (Poultry Science) and Dr. Heidi Kluess 
(Health Science, Kinesiology, Recreation and Dance) have 
been investigating the pharmacology of vasoconstriction 
in lung arterioles of the chicken. Adnan Al-Rubaye (Ph.D. 
student in my laboratory) is investigating the expression 
levels of AGTR1 in different tissues from resistant and 
susceptible chickens. Therefore, Russell’s contribution is a set 
of molecular tools that will allow us to correlate particular 
AGTR1 alleles with gene expression levels, physiological 
responses, and prediction of ascites phenotype. 
What is truly exciting about this is that the research at the 
University of Arkansas has been demonstrating that the 
chicken may very well be one of the best medical models 
for PAH in humans. The AGTR1 work is part of that and 
demonstrates that the chicken has many of the same 
underlying physiological and genetic bases for PAH as found 
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in humans. Thus, we are not only going to understand the 
disease to minimize the impact on the poultry industry, but 
may also develop an excellent model for understanding and 
developing new treatments for the disease in humans. 
This work has been funded by grants to Drs. Anthony and 
Rhoads from the Arkansas Biosciences Institute, and to Dr. 
Wideman from the National Institutes of Health. 
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